S
Stewart G. Albert
Researcher at Saint Louis University
Publications - 83
Citations - 2077
Stewart G. Albert is an academic researcher from Saint Louis University. The author has contributed to research in topics: Diabetes mellitus & Insulin. The author has an hindex of 25, co-authored 79 publications receiving 1828 citations. Previous affiliations of Stewart G. Albert include Memorial Hospital of South Bend.
Papers
More filters
Journal ArticleDOI
The effect of etomidate on adrenal function in critical illness: a systematic review.
TL;DR: There is an increased rate of AI and mortality in critically ill patients who received etomidate and non-etomidate anesthesia, and this results in an increased risk ratio (RR) for AI.
Journal ArticleDOI
Narrative Review: A Rational Approach to Starting Insulin Therapy
TL;DR: This review describes 3 common blood glucose profiles that represent typical patterns among patients with diabetes and suggests an initial insulin regimen that would then be modified according to individual responsiveness, based on previously published manuscripts identified through a MEDLINE search.
Journal ArticleDOI
Impact of glycemic control strategies on the progression of diabetic peripheral neuropathy in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Cohort.
Rodica Pop-Busui,Jiang Lu,Maria M. Brooks,Stewart G. Albert,Andrew D. Althouse,Jorge Escobedo,Jenifer Green,Pasquale Palumbo,Bruce A. Perkins,Fred W. Whitehouse,Teresa L.Z. Jones +10 more
TL;DR: Among patients with type 2 diabetes followed for up to 4 years during BARI 2D, a glycemic control therapy with IS significantly reduced the incidence of DPN compared with IP therapy and may add further benefit for men.
Journal ArticleDOI
Pheochromocytoma as a reversible cause of cardiomyopathy: Analysis and review of the literature.
TL;DR: The study highlights the importance of early suspicion and diagnosis of pheochromocytoma in cases of idiopathic heart failure as early resection may prevent progression to irreversible myocardial remodeling and death.
Journal ArticleDOI
Thyroid dysfunction during chronic amiodarone therapy
TL;DR: There was no pattern to the time course for development of thyroid dysfunction, which occurred in 49% of those followed up and developed as early as 1 month or, in one individual, as late as after 3 years of amiodarone therapy.